RxSight, Inc. RXST
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.22% | -5.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.22% | -5.26% | |||
| Cost of Revenue | 6.22% | 0.68% | |||
| Gross Profit | 10.16% | -6.99% | |||
| SG&A Expenses | -4.51% | 15.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.49% | 10.87% | |||
| Operating Income | 22.77% | -57.26% | |||
| Income Before Tax | 24.37% | -73.59% | |||
| Income Tax Expenses | 1,366.67% | 20.00% | |||
| Earnings from Continuing Operations | 23.84% | -73.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.84% | -73.56% | |||
| EBIT | 22.77% | -57.26% | |||
| EBITDA | 24.85% | -62.07% | |||
| EPS Basic | 24.16% | -72.96% | |||
| Normalized Basic EPS | 24.69% | -73.05% | |||
| EPS Diluted | 24.16% | -72.96% | |||
| Normalized Diluted EPS | 24.69% | -73.05% | |||
| Average Basic Shares Outstanding | 0.45% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||